Genelux Corp Files 8-K: Board & Officer Changes
Ticker: GNLX · Form: 8-K · Filed: Feb 3, 2025 · CIK: 1231457
| Field | Detail |
|---|---|
| Company | Genelux Corp (GNLX) |
| Form Type | 8-K |
| Filed Date | Feb 3, 2025 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.001, $180,000, $410,000, $3.95 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing
TL;DR
Genelux Corp 8-K: Board and exec changes filed Jan 29, 2025.
AI Summary
On January 29, 2025, Genelux Corporation filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to compensatory arrangements. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Westlake Village, California.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is primarily procedural, reporting changes in corporate governance and including financial statements, without announcing significant new risks or opportunities.
Key Players & Entities
- Genelux Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Westlake Village, California (location) — Principal executive offices
FAQ
What specific changes were made to the board of directors or executive officers?
The filing indicates changes in directors and certain officers, and updates to compensatory arrangements, but does not specify the names or exact nature of these changes within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on January 29, 2025.
What is Genelux Corporation's Standard Industrial Classification (SIC) code?
Genelux Corporation's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where are Genelux Corporation's principal executive offices located?
Genelux Corporation's principal executive offices are located at 2625 Townsgate Road, Suite 230, Westlake Village, California, 91361.
What is the SEC file number for Genelux Corporation?
The SEC file number for Genelux Corporation is 001-41599.
Filing Stats: 1,573 words · 6 min read · ~5 pages · Grade level 12.3 · Accepted 2025-02-03 06:08:14
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 per share GNLX The Nasdaq Stock Mar
- $180,000 — e (in the total amount of approximately $180,000), subject to standard payroll deduction
- $410,000 — . Pulisic will receive a base salary of $410,000 per year and be eligible for an annual
- $3.95 — ith a per share exercise price equal to $3.95 per share (the " Option "). The shares
Filing Documents
- form8-k.htm (8-K) — 56KB
- ex10-1.htm (EX-10.1) — 58KB
- 0001493152-25-004554.txt ( ) — 302KB
- gnlx-20250129.xsd (EX-101.SCH) — 3KB
- gnlx-20250129_lab.xml (EX-101.LAB) — 33KB
- gnlx-20250129_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Separation Agreement, dated January 29, 2025, by and between Genelux Corporation and Lourie Zak. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Genelux Corporation Date: February 3, 2025 By: /s/ Thomas Zindrick, J.D. Thomas Zindrick, J.D. President and Chief Executive Officer